Autogreffes de cellules souches hématopoïétiques en oncologie pédiatrique ; étude des complications infectieuses survenant au cours de la première année après sortie d'aplasie

Conclusion. - Our study shows that infections in the first year postengrafment following autologous stem cell transplantation for solid tumors have a good prognosis and that the use of TMP/SMX should be the single systematic antimicrobial prophylaxis. The CD34+ cell dose seems to play a role in preventing late infections.